Clinical Trials in Miami

Showing 3141-3160 of 9,821 trials

Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFα Therapy Response in Moderate to Severe Active RA

NCT05246280

This study will confirm the ability of Tc 99m tilmanocept imaging to predict clinical response in individuals with RA who are beginning anti-TNFα therapy.

Rheumatoid Arthritis

Navidea Biopharmaceuticals169 participantsStarted Mar 2022

Beverly Hills, California, United States • San Francisco, California, United States • Avon Park, Florida, United States +10 more locations

COMPLETEDPhase 2/3< 1 mile

Novel Experimental COVID-19 Therapies Affecting Host Response

NCT04924660

The overarching goal of the Master Protocol is to find effective strategies for inpatient management of patients with COVID-19. Therapeutic goals for patients hospitalized for COVID-19 include hastening recovery and preventing progression to critical illness, multiorgan failure, or death. Our objective is to determine whether modulating the host tissue response improves clinical outcomes among patients with COVID-19. The primary analysis will include data from NCT05593770.

COVID-19SARS-CoV-2 InfectionCoronavirus Infection

Sean Collins1,060 participantsStarted Jul 2021

Birmingham, Alabama, United States • Chandler, Arizona, United States • Los Angeles, California, United States +48 more locations

Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFα Therapy Response in Moderate to Severe Active RA

Novel Experimental COVID-19 Therapies Affecting Host Response

Find Trials by Condition in Miami

Evaluation of the Pharmacokinetics and Safety of Inaxaplin in Participants With Mild or Moderate Hepatic Impairment

ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection

Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate)

Ostomy Belt Use Associated Quality of Life

A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

A Study to Evaluate the Safety, and Tolerability, and Efficacy of Seladelpar in Patients With PSC

Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation

Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting

The Gilenya Pregnancy Registry

CLUSTER Trial for Outbreak Detection and Response

Intermediate-Size Expanded Access Protocol (EAP) for LP352

Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation

Non-Complex Biliary Stones DSC vs ERC

Safety of a Three-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-045)

International obServational sTudy on AiRway manaGement in operAting Room and Non-operaTing Room anaEsthesia

International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab

Extension to the MAGNIFY MS Trial on Mavenclad® (Magnify MS Extension)